{"id":352181,"date":"2026-11-18T11:24:16","date_gmt":"2026-11-18T05:54:16","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=352181"},"modified":"2026-11-18T11:24:16","modified_gmt":"2026-11-18T05:54:16","slug":"why-emcure-pharmaceuticals-ltd-share-price-near-52-week-high-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-emcure-pharmaceuticals-ltd-share-price-near-52-week-high-today-2026\/","title":{"rendered":"Emcure Pharmaceuticals Ltd. (EMCURE) Pharmaceuticals Share Price near 52-week high as stock trades at Rs 2,383.80"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/emcure\/emcure-pharmaceuticals-ltd-share-price-today\">Emcure Pharmaceuticals Ltd. (EMCURE)<\/a> share price is trading within 2% of its 52-week high today and stood at Rs 2,383.8, up 1.92% from the previous close. Market cap was Rs 44,378.06 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\">Emcure Pharmaceuticals Share Price is Rs 2,383.80, up 1.92%, and trading near its 52-week high. The company\u2019s market capitalisation stands at Rs 44,378.06 crore, keeping Emcure Pharmaceuticals Share Price in focus for market watchers.<\/p>\n<p style=\"margin-top:0!important;\">Emcure Pharmaceuticals Share Price is Rs 2,383.80 at 18 November 2026 at 11:22 AM IST, up 1.92% from the previous close of Rs 2,339. The stock is trading close to its 52-week high after touching an intraday high of Rs 2,384.95, while market capitalisation stands at Rs 44,378.06 crore. That makes Emcure Pharmaceuticals Share Price one of the day\u2019s notable stock news items in the healthcare space. According to latest Univest data, the price event is clear, but it does not establish a company-specific catalyst. For investors tracking Emcure Pharmaceuticals Share Price Today, the focus is on the exact move, the price band, and the fundamental profile behind the stock\u2019s current valuation.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-emcure-pharmaceuticals-ltd-share-price-near-52-week-high-today-2026\/#Emcure_Pharmaceuticals_Share_Price_Today_Price_Action_Analysis\" title=\"Emcure Pharmaceuticals Share Price Today: Price Action Analysis\">Emcure Pharmaceuticals Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-emcure-pharmaceuticals-ltd-share-price-near-52-week-high-today-2026\/#Emcure_Pharmaceuticals_Ltd_EMCURE_Fundamental_Analysis\" title=\"Emcure Pharmaceuticals Ltd. (EMCURE) Fundamental Analysis\">Emcure Pharmaceuticals Ltd. (EMCURE) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-emcure-pharmaceuticals-ltd-share-price-near-52-week-high-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-emcure-pharmaceuticals-ltd-share-price-near-52-week-high-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-emcure-pharmaceuticals-ltd-share-price-near-52-week-high-today-2026\/#Why_Investors_Are_Watching_Emcure_Pharmaceuticals\" title=\"Why Investors Are Watching Emcure Pharmaceuticals\">Why Investors Are Watching Emcure Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-emcure-pharmaceuticals-ltd-share-price-near-52-week-high-today-2026\/#About_Emcure_Pharmaceuticals\" title=\"About Emcure Pharmaceuticals\">About Emcure Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-emcure-pharmaceuticals-ltd-share-price-near-52-week-high-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-emcure-pharmaceuticals-ltd-share-price-near-52-week-high-today-2026\/#Why_is_Emcure_Pharmaceuticals_Share_Price_in_focus_today\" title=\"Why is Emcure Pharmaceuticals Share Price in focus today?\">Why is Emcure Pharmaceuticals Share Price in focus today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-emcure-pharmaceuticals-ltd-share-price-near-52-week-high-today-2026\/#What_is_Emcure_Pharmaceuticals_Share_Price_today\" title=\"What is Emcure Pharmaceuticals Share Price today?\">What is Emcure Pharmaceuticals Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-emcure-pharmaceuticals-ltd-share-price-near-52-week-high-today-2026\/#How_much_did_Emcure_Pharmaceuticals_Share_Price_move_today\" title=\"How much did Emcure Pharmaceuticals Share Price move today?\">How much did Emcure Pharmaceuticals Share Price move today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-emcure-pharmaceuticals-ltd-share-price-near-52-week-high-today-2026\/#Is_Emcure_Pharmaceuticals_Share_Price_near_its_52-week_high\" title=\"Is Emcure Pharmaceuticals Share Price near its 52-week high?\">Is Emcure Pharmaceuticals Share Price near its 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-emcure-pharmaceuticals-ltd-share-price-near-52-week-high-today-2026\/#What_valuation_details_matter_for_Emcure_Pharmaceuticals_Share_Price\" title=\"What valuation details matter for Emcure Pharmaceuticals Share Price?\">What valuation details matter for Emcure Pharmaceuticals Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-emcure-pharmaceuticals-ltd-share-price-near-52-week-high-today-2026\/#How_does_Emcure_Pharmaceuticals_compare_with_sector_benchmarks\" title=\"How does Emcure Pharmaceuticals compare with sector benchmarks?\">How does Emcure Pharmaceuticals compare with sector benchmarks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-emcure-pharmaceuticals-ltd-share-price-near-52-week-high-today-2026\/#How_does_Emcure_Pharmaceuticals_compare_with_peers\" title=\"How does Emcure Pharmaceuticals compare with peers?\">How does Emcure Pharmaceuticals compare with peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-emcure-pharmaceuticals-ltd-share-price-near-52-week-high-today-2026\/#What_should_investors_monitor_next_in_Emcure_Pharmaceuticals_Share_Price\" title=\"What should investors monitor next in Emcure Pharmaceuticals Share Price?\">What should investors monitor next in Emcure Pharmaceuticals Share Price?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-emcure-pharmaceuticals-ltd-share-price-near-52-week-high-today-2026\/#Track_Emcure_Pharmaceuticals_Share_Price_on_Univest\" title=\"Track Emcure Pharmaceuticals Share Price on Univest\">Track Emcure Pharmaceuticals Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Emcure_Pharmaceuticals_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Emcure Pharmaceuticals Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,383.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,339<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 44.8 (+1.92%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,350<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,384.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,344<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 44,378.06 crore<\/td>\n<\/tr>\n<\/table>\n<p>Emcure Pharmaceuticals Ltd. (EMCURE) traded at Rs 2,383.8 versus the previous close of Rs 2,339, a rise of 1.92%. The stock opened at Rs 2,350, reached a high of Rs 2,384.95 and touched a low of Rs 2,344.<\/p>\n<p>Emcure Pharmaceuticals Share Price Today shows a gain of Rs 44.80 from the previous close, with the stock opening at Rs 2,350 and moving between Rs 2,344 and Rs 2,384.95 during the trading window captured at 18 November 2026 at 11:22 AM IST. The current quote of Rs 2,383.80 places Emcure Pharmaceuticals Share Price within a narrow distance of its yearly high, which is why the stock is appearing in 52 week high searches and broader share market today screens. For readers following Emcure Pharmaceuticals Share Price News, the most important factual point is that the stock is trading very close to its peak band for the year, while the latest Univest data confirms the price event without assigning a reason. Emcure Pharmaceuticals Share Price therefore remains a live market update rather than a finished-day outcome.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Emcure_Pharmaceuticals_Ltd_EMCURE_Fundamental_Analysis\"><\/span><strong>Emcure Pharmaceuticals Ltd. (EMCURE) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 44,378.06 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">40.58x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8.3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.09%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.25%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 57.64<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 281.69<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.15%<\/td>\n<\/tr>\n<\/table>\n<p>Emcure Pharmaceuticals Ltd. (EMCURE) fundamental metrics show P\/E 40.58x, P\/B 8.3x, ROE 20.09%, ROCE 25.25%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Emcure Pharmaceuticals Ltd. has a market capitalisation of Rs 44,378.06 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 40.58x, P\/B at 8.3x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.09% and ROCE of 25.25%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 57.64, book value per share of Rs 281.69, dividend yield of 0.15%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 26.36x, median ROE of 11.22%, median ROCE of 12.76%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">40.58x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.36x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">50.53x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 1,425.63x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8.3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.73x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.09%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">25.25%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.76%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 44,378.06 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 747.19 crore<\/td>\n<\/tr>\n<\/table>\n<p>Emcure Pharmaceuticals Ltd. (EMCURE) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Emcure Pharmaceuticals Ltd. (EMCURE) has a P\/E ratio of 40.58x, which is above the benchmark median of 26.36x, a difference of +53.95%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Emcure Pharmaceuticals Ltd. (EMCURE) has a ROE of 20.09%, which is above the benchmark median of 11.22%, a difference of +79.06%. Emcure Pharmaceuticals Ltd. (EMCURE) has a ROCE of 25.25%, which is above the benchmark median of 12.76%, a difference of +97.88%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/glaxo\/glaxosmithkline-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Glaxosmithkline Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GLAXO<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">44,875.66<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">39.8<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.26<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">48.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">66.79<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/ajantpharm\/ajanta-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Ajanta Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">AJANTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">41,969.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">32.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.52<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">32.67<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/ipcalab\/ipca-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Ipca Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">IPCALAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">47,360.23<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.36<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.41<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sailife\/sai-life-sciences-limited-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>SAI LIFE SCIENCES LIMITED<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SAILIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">38,264.53<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">98.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.16<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/anthem\/anthem-biosciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Anthem Biosciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ANTHEM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">52,516.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">84.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.98<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">29.62<\/td>\n<\/tr>\n<\/table>\n<p>Emcure Pharmaceuticals Ltd. (EMCURE) has a P\/E ratio of 40.58x compared with the displayed peer median of 39.8x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 20.09% compares with a peer median of 21.98% across the companies shown in the table. ROCE stood at 25.25% versus the displayed peer median of 29.62%, providing a capital-efficiency comparison. Emcure Pharmaceuticals Ltd. (EMCURE) has a market capitalisation of Rs 44,378.06 crore. Among the 5 peers shown, 3 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Emcure_Pharmaceuticals\"><\/span><strong>Why Investors Are Watching Emcure Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Emcure Pharmaceuticals Share Price is trading at Rs 2,383.80, close to its 52-week high band.<\/li>\n<li>The day\u2019s move in Emcure Pharmaceuticals Share Price is 1.92%, with a rise of Rs 44.80 from the previous close.<\/li>\n<li>Emcure Pharmaceuticals Share Price has a P\/E ratio of 40.58 and a P\/B ratio of 8.3.<\/li>\n<li>ROE at 20.09% and ROCE at 25.25% provide direct fundamental context for Emcure Pharmaceuticals Share Price.<\/li>\n<li>Emcure Pharmaceuticals Share Price stands near peers such as Glaxosmithkline Pharmaceuticals and Ajanta Pharma by market cap.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Emcure_Pharmaceuticals\"><\/span><strong>About Emcure Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Emcure Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. Emcure Pharmaceuticals Share Price reflects a listed company with a market capitalisation of Rs 44,378.06 crore and a quarterly revenue figure of Rs 2,820.47 crore for Sep 2026. The company\u2019s reported EPS is Rs 57.64, book value per share is Rs 281.69 and dividend yield is 0.15%. For readers following Emcure Pharmaceuticals Share Price Today, these are the core company details available in the latest stock news flow.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Emcure_Pharmaceuticals_Share_Price_in_focus_today\"><\/span><strong>Why is Emcure Pharmaceuticals Share Price in focus today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Emcure_Pharmaceuticals_Share_Price_today\"><\/span><strong>What is Emcure Pharmaceuticals Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Emcure Pharmaceuticals Share Price today is Rs 2,383.80 at 18 November 2026 at 11:22 AM IST. It is higher than the previous close of Rs 2,339 and sits near the year\u2019s peak zone.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Emcure_Pharmaceuticals_Share_Price_move_today\"><\/span><strong>How much did Emcure Pharmaceuticals Share Price move today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Emcure Pharmaceuticals Share Price moved up by Rs 44.80, which equals 1.92%. The stock also traded between Rs 2,344 and Rs 2,384.95 during the session captured in the latest market update.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Emcure_Pharmaceuticals_Share_Price_near_its_52-week_high\"><\/span><strong>Is Emcure Pharmaceuticals Share Price near its 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes. Emcure Pharmaceuticals Share Price is trading very close to its 52-week high after touching Rs 2,384.95 intraday. The latest price of Rs 2,383.80 keeps it in that range.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_valuation_details_matter_for_Emcure_Pharmaceuticals_Share_Price\"><\/span><strong>What valuation details matter for Emcure Pharmaceuticals Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Emcure Pharmaceuticals Share Price is backed by a P\/E of 40.58, P\/B of 8.3, EPS of Rs 57.64 and book value of Rs 281.69. Dividend yield is 0.15%, giving a full valuation view.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Emcure_Pharmaceuticals_compare_with_sector_benchmarks\"><\/span><strong>How does Emcure Pharmaceuticals compare with sector benchmarks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Emcure Pharmaceuticals Share Price stands above the industry median P\/E of 26.36 and median P\/B of 2.73. Its ROE of 20.09% and ROCE of 25.25% are also above the benchmark medians.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Emcure_Pharmaceuticals_compare_with_peers\"><\/span><strong>How does Emcure Pharmaceuticals compare with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Emcure Pharmaceuticals Share Price is close in market cap to Glaxosmithkline Pharmaceuticals and higher than Ajanta Pharma. Its P\/E is above Ajanta and Ipca, while ROE and ROCE sit in the middle of the peer set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next_in_Emcure_Pharmaceuticals_Share_Price\"><\/span><strong>What should investors monitor next in Emcure Pharmaceuticals Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors following Emcure Pharmaceuticals Share Price can monitor how the stock behaves around its current yearly high zone, along with quarterly revenue trends, earnings delivery, valuation multiples and peer comparisons over time.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why is Emcure Pharmaceuticals Share Price in focus today? What is Emcure Pharmaceuticals Share Price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Emcure Pharmaceuticals Share Price today is Rs 2,383.80 at 18 November 2026 at 11:22 AM IST. It is higher than the previous close of Rs 2,339 and sits near the year\u2019s peak zone.\"}},{\"@type\":\"Question\",\"name\":\"How much did Emcure Pharmaceuticals Share Price move today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Emcure Pharmaceuticals Share Price moved up by Rs 44.80, which equals 1.92%. The stock also traded between Rs 2,344 and Rs 2,384.95 during the session captured in the latest market update.\"}},{\"@type\":\"Question\",\"name\":\"Is Emcure Pharmaceuticals Share Price near its 52-week high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes. Emcure Pharmaceuticals Share Price is trading very close to its 52-week high after touching Rs 2,384.95 intraday. The latest price of Rs 2,383.80 keeps it in that range.\"}},{\"@type\":\"Question\",\"name\":\"What valuation details matter for Emcure Pharmaceuticals Share Price?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Emcure Pharmaceuticals Share Price is backed by a P\/E of 40.58, P\/B of 8.3, EPS of Rs 57.64 and book value of Rs 281.69. Dividend yield is 0.15%, giving a full valuation view.\"}},{\"@type\":\"Question\",\"name\":\"How does Emcure Pharmaceuticals compare with sector benchmarks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Emcure Pharmaceuticals Share Price stands above the industry median P\/E of 26.36 and median P\/B of 2.73. Its ROE of 20.09% and ROCE of 25.25% are also above the benchmark medians.\"}},{\"@type\":\"Question\",\"name\":\"How does Emcure Pharmaceuticals compare with peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Emcure Pharmaceuticals Share Price is close in market cap to Glaxosmithkline Pharmaceuticals and higher than Ajanta Pharma. Its P\/E is above Ajanta and Ipca, while ROE and ROCE sit in the middle of the peer set.\"}},{\"@type\":\"Question\",\"name\":\"What should investors monitor next in Emcure Pharmaceuticals Share Price?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors following Emcure Pharmaceuticals Share Price can monitor how the stock behaves around its current yearly high zone, along with quarterly revenue trends, earnings delivery, valuation multiples and peer comparisons over time.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_Emcure_Pharmaceuticals_Share_Price_on_Univest\"><\/span><strong>Track Emcure Pharmaceuticals Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/emcure\/emcure-pharmaceuticals-ltd-share-price-today\">Emcure Pharmaceuticals Ltd. (EMCURE) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Track Emcure Pharmaceuticals Share Price on Univest to follow live price updates, market cap, valuation ratios, sector context, 52-week levels and company financials in one place. Emcure Pharmaceuticals Share Price Today pages also help readers compare the stock with peers and review current stock news and market update data.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Emcure Pharmaceuticals Ltd. Share Price trades near its 52-week high at Rs 2,383.8, marking a 1.92% rise today. Market cap stands at Rs 44,378.06 crore.<\/p>\n","protected":false},"author":38,"featured_media":352179,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-352181","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["352179"],"rank_math_title":["Emcure Pharmaceuticals Share Price holds near one-year high"],"rank_math_description":["Emcure Pharmaceuticals Share Price trades at Rs 2,383.80, up 1.92%, near its 52-week high. See price action, valuation and peer context."],"rank_math_focus_keyword":["Emcure Pharmaceuticals Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/emcure-pharmaceuticals-ltd-emcure-pharmaceuticals-share-price-near-52-week-high.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/352181","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=352181"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/352181\/revisions"}],"predecessor-version":[{"id":352182,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/352181\/revisions\/352182"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/352179"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=352181"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=352181"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=352181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}